| Product Code: ETC7653202 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Hemophilia A Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Hemophilia A Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Hemophilia A Treatment Market - Industry Life Cycle |
3.4 Israel Hemophilia A Treatment Market - Porter's Five Forces |
3.5 Israel Hemophilia A Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Hemophilia A Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Israel Hemophilia A Treatment Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Israel Hemophilia A Treatment Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.9 Israel Hemophilia A Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.10 Israel Hemophilia A Treatment Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
4 Israel Hemophilia A Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of hemophilia A in Israel |
4.2.2 Technological advancements in hemophilia A treatment options |
4.2.3 Growing healthcare expenditure and government support for hemophilia A treatment |
4.3 Market Restraints |
4.3.1 High cost of hemophilia A treatment |
4.3.2 Limited accessibility to specialized hemophilia A treatment centers |
4.3.3 Stringent regulatory requirements for hemophilia A treatment products |
5 Israel Hemophilia A Treatment Market Trends |
6 Israel Hemophilia A Treatment Market, By Types |
6.1 Israel Hemophilia A Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Hemophilia A Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Hemophilia A Treatment Market Revenues & Volume, By Severe, 2021- 2031F |
6.1.4 Israel Hemophilia A Treatment Market Revenues & Volume, By Moderate, 2021- 2031F |
6.1.5 Israel Hemophilia A Treatment Market Revenues & Volume, By Mild, 2021- 2031F |
6.2 Israel Hemophilia A Treatment Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Israel Hemophilia A Treatment Market Revenues & Volume, By Recombinant Factor Concentrates, 2021- 2031F |
6.2.3 Israel Hemophilia A Treatment Market Revenues & Volume, By Plasma-derived Factor Concentrates, 2021- 2031F |
6.2.4 Israel Hemophilia A Treatment Market Revenues & Volume, By Extended Half-life Products, 2021- 2031F |
6.3 Israel Hemophilia A Treatment Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Israel Hemophilia A Treatment Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.3.3 Israel Hemophilia A Treatment Market Revenues & Volume, By Adult, 2021- 2031F |
6.4 Israel Hemophilia A Treatment Market, By Diagnosis |
6.4.1 Overview and Analysis |
6.4.2 Israel Hemophilia A Treatment Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.4.3 Israel Hemophilia A Treatment Market Revenues & Volume, By Fibrinogen Test, 2021- 2031F |
6.4.4 Israel Hemophilia A Treatment Market Revenues & Volume, By Factor VIII and Factor IX Tests, 2021- 2031F |
6.4.5 Israel Hemophilia A Treatment Market Revenues & Volume, By Prothrombin Time (PT), 2021- 2031F |
6.4.6 Israel Hemophilia A Treatment Market Revenues & Volume, By Complete Blood Count (CBC), 2021- 2031F |
6.5 Israel Hemophilia A Treatment Market, By Treatment |
6.5.1 Overview and Analysis |
6.5.2 Israel Hemophilia A Treatment Market Revenues & Volume, By Prophylaxis, 2021- 2031F |
6.5.3 Israel Hemophilia A Treatment Market Revenues & Volume, By On Demand, 2021- 2031F |
6.6 Israel Hemophilia A Treatment Market, By Therapy |
6.6.1 Overview and Analysis |
6.6.2 Israel Hemophilia A Treatment Market Revenues & Volume, By Factor Replacement Therapy, 2021- 2031F |
6.6.3 Israel Hemophilia A Treatment Market Revenues & Volume, By Non-factor Replacement Therapy, 2021- 2031F |
7 Israel Hemophilia A Treatment Market Import-Export Trade Statistics |
7.1 Israel Hemophilia A Treatment Market Export to Major Countries |
7.2 Israel Hemophilia A Treatment Market Imports from Major Countries |
8 Israel Hemophilia A Treatment Market Key Performance Indicators |
8.1 Number of hemophilia A patients diagnosed annually |
8.2 Adoption rate of advanced hemophilia A treatment technologies |
8.3 Percentage of government funding allocated to hemophilia A treatment |
8.4 Patient satisfaction with hemophilia A treatment services |
8.5 Rate of adherence to hemophilia A treatment regimens |
9 Israel Hemophilia A Treatment Market - Opportunity Assessment |
9.1 Israel Hemophilia A Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Hemophilia A Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Israel Hemophilia A Treatment Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Israel Hemophilia A Treatment Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.5 Israel Hemophilia A Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.6 Israel Hemophilia A Treatment Market Opportunity Assessment, By Therapy, 2021 & 2031F |
10 Israel Hemophilia A Treatment Market - Competitive Landscape |
10.1 Israel Hemophilia A Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Hemophilia A Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here